The NIAID is offering this grant to solicit applications for its Autoimmunity Centers of Excellence (ACE) Clinical Research Program. This grant is for establishing a cooperative network aimed at significantly improving the understanding, prevention, and treatment of autoimmune diseases. The ACE program emphasizes collaboration between basic and clinical scientists to accelerate fundamental and applied research. Recipients of this Clinical Research Program grant will conduct innovative studies on human autoimmunity through clinical and collaborative projects. This initiative also involves working with the Basic ACE program members to design and execute studies on autoimmune disease pathogenesis and the mechanisms of immune-modulating interventions tested in ACE clinical trials.
Opportunity ID: 345087
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-22-071 |
| Funding Opportunity Title: | Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 22, 2022 |
| Last Updated Date: | Dec 22, 2022 |
| Original Closing Date for Applications: | May 19, 2023 |
| Current Closing Date for Applications: | May 19, 2023 |
| Archive Date: | Jun 24, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities County governments Private institutions of higher education Small businesses State governments For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to participate in the NIAID Autoimmunity Centers of Excellence (ACE), a cooperative network intended to improve the understanding, prevention, and treatment of autoimmune diseases (www.autoimmunitycenters.org). The ACE program was founded on the premise that collaborations among basic and clinical scientists can accelerate both fundamental and applied research. The ACE combines Basic and Clinical research programs. This FOA solicits applications for the Clinical research program; a companion FOA solicits applications for the Basic research program. Members of the Clinical research program will conduct innovative studies of human autoimmunity within Clinical and Collaborative Projects. Members of the Basic and Clinical ACE will work together to design and conduct studies of autoimmune disease pathogenesis and mechanisms of action of immune-modulating interventions being tested in ACE clinical trials. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-071.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 345087 Full Announcement-RFA-AI-22-071 -> RFA-AI-22-071-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00279026 | Apr 19, 2023 | May 19, 2023 | View |
Package 1
Mandatory forms
345087 RR_SF424_5_0-5.0.pdf
345087 PHS398_CoverPageSupplement_5_0-5.0.pdf
345087 RR_OtherProjectInfo_1_4-1.4.pdf
345087 PerformanceSite_4_0-4.0.pdf
345087 RR_KeyPersonExpanded_4_0-4.0.pdf
345087 RR_Budget_3_0-3.0.pdf
345087 PHS398_ResearchPlan_5_0-5.0.pdf
345087 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
345087 RR_SubawardBudget30_3_0-3.0.pdf
345087 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
